P921 Maintenance of clinical, biochemical and transmural remission in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab von Piazza O Sed, N, Maregatti, M C, Pessarelli, T, Viganò, C, Conforti, F, Noviello, D, Bezzio, C, Amoroso, C, Molteni, C, Anolli, M P, Pirola, L, Saibeni, S, Fraquelli, M, Vecchi, M, Caprioli, F

Volltext

New entity of adult ultra-short coeliac disease: the first international cohort and case–control study von Raju, S.A, Greenaway, E.A, Schiepatti, A, Arpa, G, Vecchione, N, Jian, C.L.A, Grobler, C, Maregatti, M, Green, O, Bowker-Howell, F.J, Shiha, M.G, Penny, H.A, Cross, S.S, Ciacci, C, Rostami, K, Ahmadipour, S, Moradi, A, Rostami-Nejad, M, Biagi, F, Volta, U, Fiorentino, M, Lebwohl, B, Green, P.H.R, Lewis, S, Molina-Infante, J, Mata-Romero, P, Vaira, V, Elli, L, Soykan, I, Ensari, A, Sanders, D.S

Volltext bestellen